Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aizant Drug Research Solutions Pvt. Ltd.
| Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH |
| Aizant Drug Research Solutions Pvt. Ltd. |
| 1:2018cv01783 |
| November 13, 2018 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 7, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Richard Juang for Aizant Drug Research Solutions Pvt. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang filed by Aizant Drug Research Solutions Pvt. Ltd. Signed by Judge Colm F. Connolly on 1/4/2019. (fms)
|
| Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang - filed by Aizant Drug Research Solutions Pvt. Ltd.. (Stamoulis, Stamatios) |
|
Filing 12
Order Setting Scheduling Conference: A Scheduling Conference is set for 3/4/2019 at 02:30 PM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/3/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf)
|
| Filing 11 ANSWER to #7 Answer to Complaint,, Counterclaim, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Filing 10 Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding coordinated discovery and Markman proceedings, and to request a scheduling conference. (Blumenfeld, Jack) |
|
Filing 9
ORDER, IT IS ORDERED that, on or before January 2, 2019, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/2/2019.) Signed by Judge Colm F. Connolly on 12/17/2018. Associated Cases: 1:18-cv-01689-CFC et al.(nmf)
|
| Filing 8 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aizant Drug Research Solutions Pvt. Ltd.. (Stamoulis, Stamatios) |
| Filing 7 ANSWER to #1 Complaint, , COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Aizant Drug Research Solutions Pvt. Ltd.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Stamoulis, Stamatios) |
| Filing 6 DECLARATION Of Mailing on Aizant Drug Research Pvt. Ltd. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01757-CFC, 1:18-cv-01758-CFC, 1:18-cv-01762-CFC through 1:18-cv-01765-CFC, 1:18-cv-01779-CFC, 1:18-cv-01783-CFC, and 1:18-cv-01785-CFC through 1:18-cv-01789-CFC (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (ceg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,551,957 B2; 9,949,998 B2. (ceg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/4/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 2/1/2022. (ceg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Aizant Drug Research Solutions Pvt. Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2502403.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation. (Attachments: #1 Exhibits 1-2, #2 Civil Cover Sheet)(ceg) |
| Summons Issued with Magistrate Consent Notice attached as to Aizant Drug Research Solutions Pvt. Ltd. on 11/13/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
